Literature DB >> 9358770

Mononuclear phagocyte hydrolytic enzyme activity associated with cerebral HIV-1 infection.

B B Gelman1, D A Wolf, M Rodriguez-Wolf, A B West, A K Haque, M Cloyd.   

Abstract

In patients with HIV encephalitis, activated macrophages and microglial cells in the brain are infected by the human immunodeficiency virus (HIV-1). Immune activation can release neurotoxic chemicals including cytokines, free radicals, autocoids, and hydrolytic enzymes. In this study, the presence of hydrolytic enzymes in acquired immune deficiency syndrome (AIDS)-related neurodegeneration was addressed. Activities of four lysosomal hydrolases were assayed in the frontal lobe of 69 males who died with AIDS and 31 age-matched control men. Activities of all four enzymes were increased significantly (1.6 to 3.6 times) in white matter of patients with AIDS. Less pronounced increases were present in cerebral cortex. Of 69 of the subjects with AIDS, 50 (72%), had at least one abnormally active enzyme. Patients with HIV encephalitis and other neuropathological changes were affected as were many subjects without any clear neuropathological anomaly. Lysosomal cathepsin D immunostaining revealed increased lysosomes within perivascular macrophages, multinucleated cells, activated microglial cells, and hypertrophic astrocytes. Increased enzyme activity was correlated significantly with assay results for HIV-1 DNA using the polymerase chain reaction. The release of acid hydrolases associated with cerebral HIV-1 infection could lead to unopposed hydrolysis of matrix and surface proteins. These post-translational disturbances could contribute to white matter and synaptic injury in AIDS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9358770      PMCID: PMC1858071     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  90 in total

1.  Role of proteolytic enzymes in biological regulation (a review).

Authors:  H Neurath; K A Walsh
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

2.  Treatment of experimental allergic encephalomyelitis with an inhibitor of cathepsin D (pepstatin).

Authors:  D H Boehme; H Umezawa; G Hashim; N Marks
Journal:  Neurochem Res       Date:  1978-04       Impact factor: 3.996

Review 3.  Proteolytic activity, synapse elimination, and the Hebb synapse.

Authors:  Y Liu; R D Fields; S Fitzgerald; B W Festoff; P G Nelson
Journal:  J Neurobiol       Date:  1994-03

4.  Metabolic instability of myelin proteins. Breakdown of basic protein induced by brain cathepsin D.

Authors:  M Benuck; N Marks; G A Hashim
Journal:  Eur J Biochem       Date:  1975-04-01

5.  Brain viral burden in HIV infection.

Authors:  C L Achim; R Wang; D K Miners; C A Wiley
Journal:  J Neuropathol Exp Neurol       Date:  1994-05       Impact factor: 3.685

6.  Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors.

Authors:  D O Adams
Journal:  J Immunol       Date:  1980-01       Impact factor: 5.422

7.  Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.

Authors:  S R Cohen; R M Herndon; G M McKhann
Journal:  N Engl J Med       Date:  1976-12-23       Impact factor: 91.245

8.  Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination.

Authors:  W Cammer; B R Bloom; W T Norton; S Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

9.  Decreased lysosomal dipeptidyl aminopeptidase I activity in cultured human skin fibroblasts in Duchenne's muscular dystrophy.

Authors:  B B Gelman; L Papa; M H Davis; E Gruenstein
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

10.  Secretion of lysosomal hydrolases by stimulated and nonstimulated macrophages.

Authors:  J Schnyder; M Baggiolini
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Role of endolysosomes and inter-organellar signaling in brain disease.

Authors:  Zahra Afghah; Xuesong Chen; Jonathan D Geiger
Journal:  Neurobiol Dis       Date:  2019-11-09       Impact factor: 5.996

2.  Cathepsin B and cystatin B in HIV-seropositive women are associated with infection and HIV-1-associated neurocognitive disorders.

Authors:  Yisel Cantres-Rosario; Marines Plaud-Valentín; Yamil Gerena; Richard L Skolasky; Valerie Wojna; Loyda M Meléndez
Journal:  AIDS       Date:  2013-01-28       Impact factor: 4.177

3.  Insulin-like growth factor 2 receptor is an IFNgamma-inducible microglial protein that facilitates intracellular HIV replication: implications for HIV-induced neurocognitive disorders.

Authors:  Hyeon-Sook Suh; Melissa Cosenza-Nashat; Namjong Choi; Meng-Liang Zhao; Jiu-feng Li; Jeffrey W Pollard; Randy L Jirtle; Harris Goldstein; Sunhee C Lee
Journal:  Am J Pathol       Date:  2010-10-01       Impact factor: 4.307

4.  Human microglial cell isolation from adult autopsy brain: brain pH, regional variation, and infection with human immunodeficiency virus type 1.

Authors:  Kimberly Schuenke; Benjamin B Gelman
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 2.643

5.  Induction of pathogenic sets of genes in macrophages and neurons in NeuroAIDS.

Authors:  Eleanor S Roberts; Michelle A Zandonatti; Debbie D Watry; Lisa J Madden; Steven J Henriksen; Michael A Taffe; Howard S Fox
Journal:  Am J Pathol       Date:  2003-06       Impact factor: 4.307

6.  Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis.

Authors:  Eillen J Rodriguez-Franco; Yisel M Cantres-Rosario; Marines Plaud-Valentin; Rafael Romeu; Yolanda Rodríguez; Richard Skolasky; Viviana Meléndez; Carmen L Cadilla; Loyda M Melendez
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

Review 7.  Macrophage derived cystatin B/cathepsin B in HIV replication and neuropathogenesis.

Authors:  Linda E Rivera; Krystal Colon; Yisel M Cantres-Rosario; Frances M Zenon; Loyda M Melendez
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.